NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Analysts Issue Forecasts for Five Prime Therapeutics Inc's FY2024 Earnings (NASDAQ:FPRX)
08:38am, Saturday, 22'nd Feb 2020
Five Prime Therapeutics Inc (NASDAQ:FPRX) – Analysts at Wedbush issued their FY2024 earnings estimates for shares of Five Prime Therapeutics in a report issued on Tuesday, February 18th. Wedbush ana
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More
02:39pm, Friday, 21'st Feb 2020
The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to
SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal
10:36pm, Thursday, 20'th Feb 2020
Since a major restructuring at Five Prime Therapeutics in October that kicked off a wind-down of most of its research and preclinical efforts, the company
Five Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
05:31pm, Thursday, 20'th Feb 2020
Five Prime Therapeutics (FPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Five Prime Therapeutics (FPRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
05:31pm, Thursday, 20'th Feb 2020
Five Prime Therapeutics (FPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
78 Biggest Movers From Yesterday
10:16am, Thursday, 20'th Feb 2020
Gainers
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) shares surged 44.6% to close at $5.84 on Wednesday.
Myomo, Inc. (NYSE: MYO) shares jumped 43.4% to close at $7.83 on...
51 Stocks Moving In Wednesday's Mid-Day Session
05:18pm, Wednesday, 19'th Feb 2020
Gainers
KBS Fashion Group Limited (NASDAQ: KBSF) shares jumped 74% to $3.83.
Myomo, Inc. (NYSE: MYO) gained 46.9% to $8.02 after the company signed a nationwide payer network...
's Top Upgrades, Downgrades For February 19, 2020
02:47pm, Wednesday, 19'th Feb 2020
Upgrades
Sidoti & Co. upgraded the stock for Matrix Service Co (NASDAQ: MTRX) from Neutral to Buy. In the second quarter, Matrix Service showed an EPS of $0.19...
Five Prime up 5% on Seattle Genetics license deal
02:44pm, Wednesday, 19'th Feb 2020
Five Prime Therapeutics (FPRX +5%) is up out of the gate this morning, albeit on below-average volume, in reaction to its global license agreement with Seattle Genetics (SGEN N/A) aimed at developing
Five Prime licenses antibodies to Seattle Genetics FPRX;SGEN
02:40pm, Wednesday, 19'th Feb 2020
Five Prime licenses antibodies to Seattle Genetics FPRX SGEN
BRIEF-Five Prime Therapeutics Licenses Antibodies To Seattle Genetics For Use In Novel Antibody Drug Conjugate Programs
02:34pm, Wednesday, 19'th Feb 2020
Five Prime Therapeutics Inc:
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
02:25pm, Wednesday, 19'th Feb 2020
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
10 Biggest Price Target Changes For Wednesday
01:39pm, Wednesday, 19'th Feb 2020
Citigroup raised Sprint Corp (NYSE: S) price target from $5.5 to $9.5. Sprint closed at $9.17 on Tuesday.
Wedbush lowered the price target for Five Prime Therapeutics Inc (...
Five Prime downgraded to Neutral at Wedbush as cabiralizumab study flops FPRX;BMY
12:45pm, Wednesday, 19'th Feb 2020
Five Prime downgraded to Neutral at Wedbush as cabiralizumab study flops Wedbush FPRX BMY
